Opening book details…
About this Medicine article
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer by Moore, Kathleen N.; Birrer, Michael J.; Marsters, Jim; Wang, Yulei; Choi, YounJeong; Royer-Joo, Stephanie; Lemahieu, Vanessa; Armstrong, Katy; Cordova, Julie; Samineni, Divya; Schuth, Eva; Vaze, Anjali; Maslyar, Daniel; Humke, Eric W.; Hamilton, Erika P.; Liu, Joyce F. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Moore, Kathleen N.; Birrer, Michael J.; Marsters, Jim; Wang, Yulei; Choi, YounJeong; Royer-Joo, Stephanie; Lemahieu, Vanessa; Armstrong, Katy; Cordova, Julie; Samineni, Divya; Schuth, Eva; Vaze, Anjali; Maslyar, Daniel; Humke, Eric W.; Hamilton, Erika P.; Liu, Joyce F.
- Publisher
- Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 0090-8258)
- Published
- 2020
- Field
- Medicine (Health Sciences)